<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urmj</journal-id><journal-title-group><journal-title xml:lang="ru">Уральский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Ural Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-4389</issn><publisher><publisher-name>Ural State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">urmj-56</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group></article-categories><title-group><article-title>Экспериментальные методы изучения ангиогенеза, ассоциированного с портальной гипертензией (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Portal hypertension associated angiogenesis assay in experimental studies (literature review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Арефьев</surname><given-names>Н. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Arefyev</surname><given-names>N. O.</given-names></name></name-alternatives><email xlink:type="simple">nikolai.arefyev@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гарбузенко</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Garbuzenko</surname><given-names>D. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Казачков</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Kazachkov</surname><given-names>E. L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бордуновский</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Bordunovskii</surname><given-names>V. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГБОУ ВО ЮУГМУ Минздрава РФ</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>ФГБОУ ВО ЮУГМУ Минздрава России</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>14</day><month>04</month><year>2021</year></pub-date><volume>0</volume><issue>2</issue><fpage>16</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Арефьев Н.О., Гарбузенко Д.В., Казачков Е.Л., Бордуновский В.Н., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Арефьев Н.О., Гарбузенко Д.В., Казачков Е.Л., Бордуновский В.Н.</copyright-holder><copyright-holder xml:lang="en">Arefyev N.O., Garbuzenko D.V., Kazachkov E.L., Bordunovskii V.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.umjusmu.ru/jour/article/view/56">https://www.umjusmu.ru/jour/article/view/56</self-uri><abstract><p>В обзоре представлены литературные данные о современных методах изучения ангиогенеза, ассоциированного с портальной гипертензией, в эксперименте. для поиска научных статей применялись база данных PubMed, поисковая система Google Scholar, а также пристатейные списки литературы. Соответствующие цели обзора публикации отбирались за период с 1981 по 2017 год по терминам: «портальная гипертензия», «микрокт», «ангиогенез», «иммуногистохимия», «интравитальная микроскопия», «микросферы». анализ литературы показал, что современные методы изучения внутри- и внепечёночного ангиогенеза, такие как микрокомпьютерная томография in vivo и ex vivo, интравитальная микроскопия, а также эффективные средства компьютерной обработки изображений, позволяют установить его важную роль в патогенезе портальной гипертензии. разработка способов антиангиогенной терапии, избирательно направленной на новообразованные сосуды, может быть перспективным направлением в лечении портальной гипертензии и связанных с ней осложнений.</p></abstract><trans-abstract xml:lang="en"><p>The review presents literature data on portal hypertension associated angiogenesis assay in experimental studies. The information was collected from the PubMed database, the Google Scholar retrieval system, and the reference lists from relevant publications for 1981 - 2017 using the keywords: “portal hypertension,” “jCT,” “angiogenesis,” “immunohistochemistry,” “intravital microscopy,” “microspheres.” Analysis of the literature showed that intra- and extrahepatic angiogenesis assays, such as micro-computed tomography in vivo and ex vivo, intravital microscopy, and computer image processing allow us to establish its important role in portal hypertension pathogenesis. The development of anti-angiogenic therapy, which would be focused on newly formed vessels, may be a perspective direction in the treatment of portal hypertension and its complications</p></trans-abstract><kwd-group xml:lang="ru"><kwd>портальная гипертензия</kwd><kwd>ангиогенез</kwd><kwd>иммуногистохимические методы</kwd><kwd>микрокт</kwd><kwd>интравитальная микроскопия</kwd><kwd>микросферы</kwd><kwd>portal hypertension</kwd><kwd>angiogenesis</kwd><kwd>immunohistochemistry</kwd><kwd>microCT</kwd><kwd>intravital microscopy</kwd><kwd>microspheres</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гарбузенко Д.В. Морфофункциональная перестройка печёночного сосудистого русла в патогенезе портальной гипертензии при циррозе печени. Тер арх 2014; 86 (2): 90-5.</mixed-citation><mixed-citation xml:lang="en">Гарбузенко Д.В. Морфофункциональная перестройка печёночного сосудистого русла в патогенезе портальной гипертензии при циррозе печени. Тер арх 2014; 86 (2): 90-5.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гарбузенко Д.В. Механизмы адаптации сосудистого русла к гемодинамическим нарушениям при портальной гипертензии. Вестн РАМН 2013; (1): 52-7.</mixed-citation><mixed-citation xml:lang="en">Гарбузенко Д.В. Механизмы адаптации сосудистого русла к гемодинамическим нарушениям при портальной гипертензии. Вестн РАМН 2013; (1): 52-7.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rosmorduc O. Antiangiogenic therapies in portal hypertension: a breakthrough in hepatology. Gastroenterol Clin Biol 2010; 34 (8-9): 446-9.</mixed-citation><mixed-citation xml:lang="en">Rosmorduc O. Antiangiogenic therapies in portal hypertension: a breakthrough in hepatology. Gastroenterol Clin Biol 2010; 34 (8-9): 446-9.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гарбузенко Д.В. Экспериментальные методы изучения портальной гипертензии. Рос журн гастроэнтерол гепатол колопроктол 2010; 20 (2): 4-12.</mixed-citation><mixed-citation xml:lang="en">Гарбузенко Д.В. Экспериментальные методы изучения портальной гипертензии. Рос журн гастроэнтерол гепатол колопроктол 2010; 20 (2): 4-12.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez M., Semela D., Bruix J., Colle I., Pinzani M., Bosch J. Angiogenesis in liver disease. J Hepatol 2009; 50 (3): 604-20.</mixed-citation><mixed-citation xml:lang="en">Fernandez M., Semela D., Bruix J., Colle I., Pinzani M., Bosch J. Angiogenesis in liver disease. J Hepatol 2009; 50 (3): 604-20.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">McDonald D.M., Choyke P.L. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003; 9 (6): 713-25.</mixed-citation><mixed-citation xml:lang="en">McDonald D.M., Choyke P.L. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003; 9 (6): 713-25.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Takashimizu S., Kojima S., Nishizaki Y. et al. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension. Tokai J Exp Clin Med 2011; 36 (2): 37-43.</mixed-citation><mixed-citation xml:lang="en">Takashimizu S., Kojima S., Nishizaki Y. et al. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension. Tokai J Exp Clin Med 2011; 36 (2): 37-43.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Van Steenkiste C., Trachet B., Casteleyn C. et al. Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents. Lab Invest 2010; 90 (11): 1558-72.</mixed-citation><mixed-citation xml:lang="en">Van Steenkiste C., Trachet B., Casteleyn C. et al. Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents. Lab Invest 2010; 90 (11): 1558-72.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Niggemann P., Murata S., Naito Z., Kumazaki T. A comparative study of the microcirculatory changes in the developing liver cirrhosis between the central and peripheral parts of the main lobe in mice. Hepatol Res 2004; 28 (1): 41-48.</mixed-citation><mixed-citation xml:lang="en">Niggemann P., Murata S., Naito Z., Kumazaki T. A comparative study of the microcirculatory changes in the developing liver cirrhosis between the central and peripheral parts of the main lobe in mice. Hepatol Res 2004; 28 (1): 41-48.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Vanheule E., Geerts A.M., Van Huysse J. et al. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. Int J Exp Pathol 2008; 89 (6): 419-32.</mixed-citation><mixed-citation xml:lang="en">Vanheule E., Geerts A.M., Van Huysse J. et al. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. Int J Exp Pathol 2008; 89 (6): 419-32.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Y.Y., Huang Y.T., Lin H.C. Thalidomide decreases intrahepatic resistance in cirrhotic rats. Biochem Biophys Res Commun 2009; 380 (3): 666-72.</mixed-citation><mixed-citation xml:lang="en">Yang Y.Y., Huang Y.T., Lin H.C. Thalidomide decreases intrahepatic resistance in cirrhotic rats. Biochem Biophys Res Commun 2009; 380 (3): 666-72.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Boerckel J.D., Mason D.E., McDermott A.M., Alsberg E. Microcomputed tomography: approaches and applications in bioengineering. Stem Cell Res Ther 2014; 5 (6): 144.</mixed-citation><mixed-citation xml:lang="en">Boerckel J.D., Mason D.E., McDermott A.M., Alsberg E. Microcomputed tomography: approaches and applications in bioengineering. Stem Cell Res Ther 2014; 5 (6): 144.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ehling J., Bartneck M., Wei X. et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut 2014; 63 (12): 1960-71.</mixed-citation><mixed-citation xml:lang="en">Ehling J., Bartneck M., Wei X. et al. CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut 2014; 63 (12): 1960-71.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bartneck M., Fech V, Ehling J. et al. Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. Hepatology 2016; 63 (4): 1310-24.</mixed-citation><mixed-citation xml:lang="en">Bartneck M., Fech V, Ehling J. et al. Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. Hepatology 2016; 63 (4): 1310-24.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jorgensen S.M., Demirkaya O., Ritman E.L. Threedimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. Am J Physiol 1998; 275 (3 Pt 2): H1103-14.</mixed-citation><mixed-citation xml:lang="en">Jorgensen S.M., Demirkaya O., Ritman E.L. Threedimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. Am J Physiol 1998; 275 (3 Pt 2): H1103-14.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Thabut D., Routray C., Lomberk G. et al. Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology 2011; 54 (2): 573-85.</mixed-citation><mixed-citation xml:lang="en">Thabut D., Routray C., Lomberk G. et al. Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology 2011; 54 (2): 573-85.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lin H.C., Huang Y.T., Yang Y.Y. et al. Beneficial effects of dual vascular endothelial growth factor receptor/ fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats. J Gastroenterol Hepatol 2014; 29 (5): 1073-82.</mixed-citation><mixed-citation xml:lang="en">Lin H.C., Huang Y.T., Yang Y.Y. et al. Beneficial effects of dual vascular endothelial growth factor receptor/ fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats. J Gastroenterol Hepatol 2014; 29 (5): 1073-82.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kline T.L., Knudsen B.E., Anderson J.L., Vercnocke A.J., Jorgensen S.M., Ritman E.L. Anatomy of hepatic arteriolo-portal venular shunts evaluated by 3D micro-CT imaging. J Anat 2014; 224 (6): 724-31.</mixed-citation><mixed-citation xml:lang="en">Kline T.L., Knudsen B.E., Anderson J.L., Vercnocke A.J., Jorgensen S.M., Ritman E.L. Anatomy of hepatic arteriolo-portal venular shunts evaluated by 3D micro-CT imaging. J Anat 2014; 224 (6): 724-31.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Peeters G., Debbaut C., Laleman W. et al. A multilevel framework to reconstruct anatomical 3D models of the hepatic vasculature in rat livers. J Anat 2017; 230 (3): 471-83.</mixed-citation><mixed-citation xml:lang="en">Peeters G., Debbaut C., Laleman W. et al. A multilevel framework to reconstruct anatomical 3D models of the hepatic vasculature in rat livers. J Anat 2017; 230 (3): 471-83.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Peeters G., Debbaut C., Friebel A. et al. Quantitative analysis of hepatic macro- and microvascular alterations during cirrhogenesis in the rat. J Anat 2017 Dec 4 [Epub ahead of print].</mixed-citation><mixed-citation xml:lang="en">Peeters G., Debbaut C., Friebel A. et al. Quantitative analysis of hepatic macro- and microvascular alterations during cirrhogenesis in the rat. J Anat 2017 Dec 4 [Epub ahead of print].</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hsu S.J., Lee J.Y., Lin T.Y. et al. The beneficial effects of curcumin in cirrhotic rats with portal hypertension. Biosci Rep 2017; 37 (6).</mixed-citation><mixed-citation xml:lang="en">Hsu S.J., Lee J.Y., Lin T.Y. et al. The beneficial effects of curcumin in cirrhotic rats with portal hypertension. Biosci Rep 2017; 37 (6).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Renier N., Wu Z., Simon D.J. et al. iDISCO: simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 2014; 159: 896-910.</mixed-citation><mixed-citation xml:lang="en">Renier N., Wu Z., Simon D.J. et al. iDISCO: simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 2014; 159: 896-910.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Susaki E.A., Tainaka K., Perrin D. et al. Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis. Cell 2014; 157: 726-39.</mixed-citation><mixed-citation xml:lang="en">Susaki E.A., Tainaka K., Perrin D. et al. Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis. Cell 2014; 157: 726-39.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bosch J., Groszmann R.J., Shah V.H. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol 2015; 62 (1 Suppl): S121-30.</mixed-citation><mixed-citation xml:lang="en">Bosch J., Groszmann R.J., Shah V.H. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol 2015; 62 (1 Suppl): S121-30.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Арефьев Н.О., Гарбузенко Д.В., Емельянов И.В., Хасанов Л.Р. Оценка неоангиогенеза в брыжейке тонкой кишки у крыс с моделью предпечёночной портальной гипертензии. Рос журн гастроэнтерол, гепатол, колопроктол 2017; 27 (приложение 50): 83.</mixed-citation><mixed-citation xml:lang="en">Арефьев Н.О., Гарбузенко Д.В., Емельянов И.В., Хасанов Л.Р. Оценка неоангиогенеза в брыжейке тонкой кишки у крыс с моделью предпечёночной портальной гипертензии. Рос журн гастроэнтерол, гепатол, колопроктол 2017; 27 (приложение 50): 83.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Geerts A.M., De Vriese A.S., Vanheule E. et al. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study. Liver Int 2006; 26: 889-98.</mixed-citation><mixed-citation xml:lang="en">Geerts A.M., De Vriese A.S., Vanheule E. et al. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study. Liver Int 2006; 26: 889-98.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Maksan S.M., Ryschich E., Ulger Z., Gebhard M.M., Schmidt J. Disturbance of hepatic and intestinal microcirculation in experimental liver cirrhosis. World J Gastroenterol 2005; 11 (6): 846-9.</mixed-citation><mixed-citation xml:lang="en">Maksan S.M., Ryschich E., Ulger Z., Gebhard M.M., Schmidt J. Disturbance of hepatic and intestinal microcirculation in experimental liver cirrhosis. World J Gastroenterol 2005; 11 (6): 846-9.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Yamaki K., Lindbom L., Thorlacius H., Hedqvist P., Raud J. An approach for studies of mediator-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol 1998; 123 (3): 381-9.</mixed-citation><mixed-citation xml:lang="en">Yamaki K., Lindbom L., Thorlacius H., Hedqvist P., Raud J. An approach for studies of mediator-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentery. Br J Pharmacol 1998; 123 (3): 381-9.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sumanovski L.T., Battegay E., Stumm M., van der Kooij M., Sieber C.C. Increased angiogenesis in portal hypertensive rats: role of nitric oxide. Hepatology 1999; 29 (4): 1044-9.</mixed-citation><mixed-citation xml:lang="en">Sumanovski L.T., Battegay E., Stumm M., van der Kooij M., Sieber C.C. Increased angiogenesis in portal hypertensive rats: role of nitric oxide. Hepatology 1999; 29 (4): 1044-9.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson C.R., Ponce A.M., Price R.J. Immunohistochemical identification of an extracellular matrix scaffold that microguides capillary sprouting in vivo. JHistochem Cytochem 2004; 52 (8): 1063-72.</mixed-citation><mixed-citation xml:lang="en">Anderson C.R., Ponce A.M., Price R.J. Immunohistochemical identification of an extracellular matrix scaffold that microguides capillary sprouting in vivo. JHistochem Cytochem 2004; 52 (8): 1063-72.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Abraldes J.G., Iwakiri Y., Loureiro-Silva M., Haq O., Sessa W.C., Groszmann R.J. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Physiol Gastrointest Liver Physiol 2006; 290 (5): G980-7.</mixed-citation><mixed-citation xml:lang="en">Abraldes J.G., Iwakiri Y., Loureiro-Silva M., Haq O., Sessa W.C., Groszmann R.J. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Am J Physiol Gastrointest Liver Physiol 2006; 290 (5): G980-7.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Huang H.C., Wang S.S., Hsin I.F. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats. Hepatology 2012; 56 (1): 248-58.</mixed-citation><mixed-citation xml:lang="en">Huang H.C., Wang S.S., Hsin I.F. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats. Hepatology 2012; 56 (1): 248-58.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Patsenker E., Popov Y., Stickel F. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology 2009; 50 (5): 1501-11.</mixed-citation><mixed-citation xml:lang="en">Patsenker E., Popov Y., Stickel F. Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology 2009; 50 (5): 1501-11.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Yang M., Stapor P.C., Peirce S.M., Betancourt A.M., Murfee W.L. Rat Mesentery Exteriorization: A Model for Investigating the Cellular Dynamics Involved in Angiogenesis. J Vis Exp 2012; 63: e3954.</mixed-citation><mixed-citation xml:lang="en">Yang M., Stapor P.C., Peirce S.M., Betancourt A.M., Murfee W.L. Rat Mesentery Exteriorization: A Model for Investigating the Cellular Dynamics Involved in Angiogenesis. J Vis Exp 2012; 63: e3954.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">McConnell M., Iwakiri Y. Biology of portal hypertension. Hepatol Int 2017 [Epub ahead of print].</mixed-citation><mixed-citation xml:lang="en">McConnell M., Iwakiri Y. Biology of portal hypertension. Hepatol Int 2017 [Epub ahead of print].</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Licks F., Hartmann R. M., Marques C., Schemitt E., Colares J. R., Soares M. do C. et al. N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats. World J Gastroenterol 2015; 21 (43): 12351-60.</mixed-citation><mixed-citation xml:lang="en">Licks F., Hartmann R. M., Marques C., Schemitt E., Colares J. R., Soares M. do C. et al. N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats. World J Gastroenterol 2015; 21 (43): 12351-60.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">De Backer D., Hollenberg S., Boerma C. et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007; 11 (5): R101.</mixed-citation><mixed-citation xml:lang="en">De Backer D., Hollenberg S., Boerma C. et al. How to evaluate the microcirculation: report of a round table conference. Crit Care 2007; 11 (5): R101.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">De Backer D., Creteur J., Preiser J.C., Dubois M.J., Vincent J.L. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166 (1): 98-104.</mixed-citation><mixed-citation xml:lang="en">De Backer D., Creteur J., Preiser J.C., Dubois M.J., Vincent J.L. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166 (1): 98-104.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Spronk P.E., Ince C., Gardien M.J., Mathura K.R., Oudemans-van Straaten H.M., Zandstra D.F. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360 (9343): 1395-6.</mixed-citation><mixed-citation xml:lang="en">Spronk P.E., Ince C., Gardien M.J., Mathura K.R., Oudemans-van Straaten H.M., Zandstra D.F. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360 (9343): 1395-6.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Klyscz T., Jünger M., Jung F., Zeintl H. Cap image--a new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech (Berl) 1997; 42 (6): 168-75.</mixed-citation><mixed-citation xml:lang="en">Klyscz T., Jünger M., Jung F., Zeintl H. Cap image--a new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech (Berl) 1997; 42 (6): 168-75.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Aperio Technologies I. Microvessel Analysis Algorithm, User’S Guide @ONLINE. 2008.</mixed-citation><mixed-citation xml:lang="en">Aperio Technologies I. Microvessel Analysis Algorithm, User’S Guide @ONLINE. 2008.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes-Aldasoro C.C., Williams L.J., Akerman S., Kanthou C., Tozer G.M. An automatic algorithm for the segmentation and morphological analysis of microvessels in immunostained histological tumour sections. JMicrosc 2011; 242 (3): 262-278.</mixed-citation><mixed-citation xml:lang="en">Reyes-Aldasoro C.C., Williams L.J., Akerman S., Kanthou C., Tozer G.M. An automatic algorithm for the segmentation and morphological analysis of microvessels in immunostained histological tumour sections. JMicrosc 2011; 242 (3): 262-278.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-Carrobles M.M., Tadeo I., Bueno G. et al. TMA Vessel Segmentation Based on Color and Morphological Features: Application to Angiogenesis Research. The Scientific World Journal 2013; 2013: 263190.</mixed-citation><mixed-citation xml:lang="en">Fernández-Carrobles M.M., Tadeo I., Bueno G. et al. TMA Vessel Segmentation Based on Color and Morphological Features: Application to Angiogenesis Research. The Scientific World Journal 2013; 2013: 263190.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Chojkier M., Groszmann R.J. Measurement of portal-systemic shunting in the rat by using у-labeled microspheres. Am J Physiol 1981; 240: G371-G375.</mixed-citation><mixed-citation xml:lang="en">Chojkier M., Groszmann R.J. Measurement of portal-systemic shunting in the rat by using у-labeled microspheres. Am J Physiol 1981; 240: G371-G375.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Hodeige D., de Pauw M., Eechaute W., Weyne J., Heyndrickx, G. R. On the validity of blood flow measurement using colored microspheres. Am J Physiol 1999; 276: H1150-H1158.</mixed-citation><mixed-citation xml:lang="en">Hodeige D., de Pauw M., Eechaute W., Weyne J., Heyndrickx, G. R. On the validity of blood flow measurement using colored microspheres. Am J Physiol 1999; 276: H1150-H1158.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Theodorakis N., Maluccio M., Skill N. Murine study of portal hypertension associated endothelin-1 hyporesponse. World J Gastroenterol 2015; 21 (16): 4817-28.</mixed-citation><mixed-citation xml:lang="en">Theodorakis N., Maluccio M., Skill N. Murine study of portal hypertension associated endothelin-1 hyporesponse. World J Gastroenterol 2015; 21 (16): 4817-28.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Hsu S.J., Wang S.S., Hsin I.F. et al. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis. Clin Sci (Lond) 2014; 126 (9): 633-44.</mixed-citation><mixed-citation xml:lang="en">Hsu S.J., Wang S.S., Hsin I.F. et al. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis. Clin Sci (Lond) 2014; 126 (9): 633-44.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez M., Vizzutti F., Garcia-Pagan J.C., Rodes J., Bosh J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 2004; 126: 886-94.</mixed-citation><mixed-citation xml:lang="en">Fernandez M., Vizzutti F., Garcia-Pagan J.C., Rodes J., Bosh J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 2004; 126: 886-94.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Lee P.C., Yang Y.Y., Huang C.S. et al. Concomitant ingibition of oxidative stress and angiogenesis by chronic hydrogen-rich saline and N-acetylcysteine treatments improves systemic, splanchnic and hepatic hemodynamics of cirrhotic rats. Hepatol Res 2015; 45 (5): 578-88.</mixed-citation><mixed-citation xml:lang="en">Lee P.C., Yang Y.Y., Huang C.S. et al. Concomitant ingibition of oxidative stress and angiogenesis by chronic hydrogen-rich saline and N-acetylcysteine treatments improves systemic, splanchnic and hepatic hemodynamics of cirrhotic rats. Hepatol Res 2015; 45 (5): 578-88.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Van Steenkiste C., Staelens S., Deleye S. et al. Measurement of porto-systemic shunting in mice by novel three-dimensional micro-single photon emission computed tomography imaging enabling longitudinal follow-up. Liver Int 2010; 30 (8): 1211-20.</mixed-citation><mixed-citation xml:lang="en">Van Steenkiste C., Staelens S., Deleye S. et al. Measurement of porto-systemic shunting in mice by novel three-dimensional micro-single photon emission computed tomography imaging enabling longitudinal follow-up. Liver Int 2010; 30 (8): 1211-20.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
